Pharmacokinetics (PK) Director, Anovent Pharmaceuticals (Recruitment Information of Shanghai Anovent Pharmaceutical Co.,)
Anovent Pharmaceuticals is an innovative company which is focusing on the research, development, production and sales of respiratory medicines. As an international pharmaceutical company in respiratory area, Anovent is dedicated to provide affordable respiratory medicines for patients worldwide.
Primary role of pharmacokinetics director is to lead Anovent pharmacokinetics (PK) science team, provide PK strategies and ensure PK objectives achieved successfully for Anovent products as the portfolio and organization expand.
Core Accountabilities/Responsibilities
Ø Design, plan, monitor and conduct pharmacokinetics studies for Anovent drug discovery and development.
Ø Analyze, model and interpret PK data, and develop the strategy for identifying and solving PK issues and challenges.
Ø Interact efficiently and professionally across groups, including interdisciplinary departments, regulatory agencies, and functional groups as the PK expert.
Ø Responsible for authoring PK reports and PK sections of regulatory documents in accordance with regulatory standards
Ø Provide leadership and guidance (including training) to other members of PK staff.
Requirements
Ø PhD degree in pharmacokinetics or related disciplines.
Ø 2+ years’ work experience in the pharmacokinetics or related areas.
Ø Generic drug experience highly preferred, especially in US ANDA.
Ø DPI or inhalation product experience highly preferred.
Ø Strong understanding of PK process and techniques.
Ø Good computer skills and strong PK technique skills.
Ø Strong ability in English, including listening, speaking, reading and writing.
Ø Excellent leadership skills.
Ø Demonstrated ability for critical thinking, problem-solving and innovation.
Ø Strong interpersonal skills to ensure effective communication, collaboration and negotiation.
Ø Strong project management and organizational skills, prioritizes and plans work activities.
Ø Strong sense of value of investment and ability to develop cost-effective development plans.
Ø Potential to take on increasing responsibilities as the portfolio and organization expands.
